The latest results from the clinical trials of Israel’s homegrown COVID-19 vaccine, BriLife, show that it is at least 80 percent effective at preventing severe disease and may provide longer-lasting protection.
Channel 12 reported on Friday that the government-run Israel Institute for Biological Research (IIBR) in Ness Ziona indicated that, so far, over 80% of volunteers who received the two-shot Israeli vaccine at its highest doses during clinical trials developed antibodies, suggesting an efficacy rate of 80%.
These high doses were trialed in Israel and are being applied in Georgia and Ukraine where the jab is being tested in Phase IIb/III trials with unvaccinated volunteers over the age of 18.
The institute hopes that additional results will show the vaccine to be up to 85% effective, according to the report.
This would make BriLife, pending results from Phase III studies, one of the most effective non-mRNA vaccine, with the AstraZeneca jab demonstrating approximately 74% efficacy and the Johnson & Johnson Janssen shot showing 85.4% efficacy against severe disease and 93.1 % against hospitalization.
Read more at Times of Israel.
{Matzav.com}
80% HASHEM YISHMOR! By now, we all know what these faxes are “effective” for…
Then how come Israel has the highest rate of infection in the world??!!
Why do u continue to print lies??!!
Unlike Dr. Zev Zelenko who’s threatened daily, he’s not afraid to say the truth.